The Estée Lauder Companies Inc.

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +45

Estée Lauder: HSBC raises TP to $110 but remains cautious

Analyst upgrade Company update AI-generated analysis

📈 HSBC raises price target to $110 from $95 while maintaining a Hold rating on Estée Lauder shares.

📊 Estée Lauder delivered 6% organic growth in Q1 2027, beating consensus of 4.4% and matching bank estimates.

💰 Operating income surged to $449m versus $346m consensus, with EPS reaching $0.72 against $0.51 expectations.

📉 Gross and operating margins expanded by 240bp and 480bp respectively, supported by an 8% year-over-year rise in consumer investments.

✨ Fragrance division led with exceptional 20% organic growth driven by a successful product launch calendar.

⚠️ Makeup and hair care segments disappointed with virtually no collective growth, lagging behind market expectations.

🔄 Management is executing the Profit Recovery & Growth Plan (PRGP) involving restructuring and cost reductions.

🎯 Company unveiled 2030 targets including operating margins of 16.5%-18.5% and steady EPS growth of 4%-6%.

📈 HSBC raised EPS estimates by 4% to $14, valuing the stock at 25x expected earnings for June 2028.

🔍 Bank remains cautious about reliance on fragrance performance and questions aggressive enough revenue acceleration.

Bullish Signals
  • Estée Lauder delivered a strong first quarter with 6% organic growth, exceeding consensus of 4.4% and aligning with HSBC's estimate of 5.8%.
  • Operating income reached $449 million, significantly beating the consensus of $346 million, demonstrating robust profitability.
  • EPS of $0.72 surpassed expectations of $0.51, reflecting strong earnings performance and effective cost management.
  • Gross and operating margins increased by 240bp and 480bp respectively, indicating improved operational efficiency.
  • The Fragrance division achieved exceptional 20% organic growth, driven by a busy product launch calendar that paid off well.
  • Consumer investments rose 8% year-over-year, supporting the margin expansion and overall business momentum.
  • Management is making clear progress on the Profit Recovery & Growth Plan (PRGP) with organizational restructuring and cost reductions.
Risk Factors
  • Growth remains unbalanced as makeup and hair care segments posted virtually no growth, collectively falling below market expectations.
  • HSBC questions whether the group could be more aggressive on consumer spending to accelerate revenue momentum beyond fragrances.
  • The stock valuation of 25x expected earnings reflects investor concerns about weakness in sales outside the fragrance division.
  • Reliance on the exceptional performance of the Fragrance division indicates that significant work remains to be done in other competitive segments.
Full Analysis
HSBC has raised its price target for Estée Lauder (EL) to $110 from $95 while maintaining a Hold rating, citing strong first-quarter results and an upgraded full-year guidance. The US cosmetics giant reported 6% organic growth in Q1 2027, surpassing consensus estimates of 4.4%, with operating income reaching $449 million against expectations of $346 million. Earnings per share beat forecasts at $0.72 versus $0.51, driven by significant margin expansions of 240 basis points for gross margins and 480 basis points for operating margins. The financial strength was primarily fueled by the Fragrance division, which achieved exceptional 20% organic growth supported by a busy product launch calendar. However, this performance masked underlying weaknesses in other key segments; makeup and hair care posted virtually no collective growth, falling below market expectations. Management is executing its Profit Recovery & Growth Plan (PRGP) to address these disparities through organizational restructuring, cost reductions, and leadership changes aimed at improving innovation and digital acquisition. Estée Lauder has unveiled ambitious targets for fiscal 2030, aiming for operating margins between 16.5% and 18.5% alongside steady EPS growth of 4% to 6%. While HSBC acknowledges the progress on the US group's transformation plan, it remains cautious about the uneven nature of the growth and questions whether management could be more aggressive in accelerating revenue momentum beyond fragrances. The bank notes that a sustained stock revaluation will depend on restoring balanced volume growth across all business segments. Under HSBC's revised forecasts, the stock trades at 25 times expected earnings for June 2028, reflecting strong future profits but also investor concerns regarding sales weakness outside the fragrance category. The bank raised its EPS estimates by 4% to $14 but maintains that consistent organic sales growth of around 6% or higher is necessary to incorporate these new targets and justify a valuation re-rating.